Phillips Electronics North America Corp. has recalled 71 HeartStart MRx defibrillators produced in September and October 2016 due to a defect that may cause the device to fail, the Food and Drug Administration announced Friday. If used in automated external defibrillator mode after failing, the device will not delivery patient therapy, which may lead to serious patient injury or death, the agency said. For more information and a list of affected devices, see the FDA notice.

Related News Articles

Headline
The Centers for Disease Control and Prevention today activated its Emergency Operations Center to support the interagency response to the Ebola outbreak in…
Headline
The World Health Organization has confirmed the first cases of Ebola in Uganda since 2013.
Blog
In this AHA Stat blog, Institute for Diversity and Health Equity President and CEO Duane Reynolds highlights various resources, programs and efforts to help…
Headline
President Trump yesterday signed legislation providing $19.1 billion in disaster relief for areas affected by hurricanes, wildfires and other recent natural…
Headline
The Centers for Disease Control and Prevention this week announced an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and Drug…
Headline
The Centers for Disease Control and Prevention yesterday reported 1,001 cases of measles so far this year, according to the Department of Health and Human…